Directed share issue in Q-linea AB — SEK 301 million

Carnegie acted as joint bookrunner in the directed share issue of 2,200,000 new shares at a subscription price of SEK 137 per share. Q-linea is a diagnostic company focused on developing and delivering solutions for healthcare providers, enabling them to accurately diagnose and treat infectious diseases in the shortest possible time.
June 2021.